These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29452091)

  • 1. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
    Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
    Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
    Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
    J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and Clinical Significance of Galcetin-3 in the Serum of Non-small Cell Lung Cancer Patients].
    Qi D; Zhang Y; Li H; Wang R; Qian K
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):333-336. PubMed ID: 32429635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
    Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
    Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
    Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
    J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell-derived exosomal circUSP7 induces CD8
    Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB
    Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer.
    Chang W; Zhu J; Yang D; Shang A; Sun Z; Quan W; Li D
    Respir Res; 2023 May; 24(1):140. PubMed ID: 37259101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Protein Profiling and mRNA Expression of LLC Exosomes.
    Zhang W; He P; Wang S; Adili A; Chen Z; Zhang CY; Jiang X; Li J; Zhang Y
    Protein J; 2019 Oct; 38(5):586-597. PubMed ID: 31214853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mtDNA fragments within exosomes might be novel diagnostic biomarkers of non-small cell lung cancer.
    Lou C; Ma X; Chen Z; Zhao Y; Yao Q; Zhou C; Zhao X; Meng X
    Pathol Res Pract; 2023 Sep; 249():154718. PubMed ID: 37544132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells.
    Pan D; Chen J; Feng C; Wu W; Wang Y; Tong J; Zhou D
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer.
    Bai J; Li X; Tong D; Shi W; Song H; Li Q
    Tumour Biol; 2013 Apr; 34(2):805-9. PubMed ID: 23359271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
    Su Y; Yamazaki S; Morisue R; Suzuki J; Yoshikawa T; Nakatsura T; Tsuboi M; Ochiai A; Ishii G
    Pathobiology; 2021; 88(3):218-227. PubMed ID: 33321503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.